COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics to Present at the 2019 Morgan Stanley Global Healthcare Conference
30/08/2019
SALT LAKE CITY, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)
30/08/2019
NEW YORK and LONDON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
Lexicon Pharmaceuticals To Present At Upcoming Investor Conference
30/08/2019
THE WOODLANDS, Texas, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Oncology Venture publishes Interim Report for the period January – June 2019
30/08/2019
Company Announcement Hoersholm, Denmark – August 30, 2019 – Oncology Venture A/S (OV:ST) (“Oncology Venture”) today announces the Interim Report for the period January – June 2019. The report is available as an attached [...]
Teleflex to Showcase its Peripheral Intervention Product Portfolio Highlighting the Arrow® OnControl® Powered Bone Access System and the MANTA™ Vascular Closure Device at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019
30/08/2019
WAYNE, Pa., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, will showcase its Peripheral Intervention product portfolio including the Arrow ® [...]
Coloplast: Announcement no. 09/2019 - Financial calendar 2019/20
30/08/2019
Please see enclosed pdf. Attachment 9-19 Financial Calendar 2019-20
Media Advisory - Save Your Skin lance le premier défi « Move For Melanoma » au bénéfice des patients atteints de cancer de la peau au Canada
30/08/2019
Ce défi unique d'activité physique aura lieu sur l'ensemble du Canada du 13 au 16 septembre VANCOUVER, Colombie-Britannique, 30 août 2019 (GLOBE NEWSWIRE) -- Le vendredi 13 septembre, Save Your Skin Foundation lancera [...]
Les résultats financiers d'Emerald Health Therapeutics au deuxième trimestre 2019 indiquent un doublement des ventes pour le deuxième trimestre consécutif
30/08/2019
La coentreprise Pure Sunfarms détenue à 50 % par Emerald réalise un chiffre d'affaires de 32,4 millions $ au deuxième trimestre, une marge de BAIIA de 78 %, un coût de production global de 0,65 $/g et un troisième [...]
Veta™ Smart Case & App for epinephrine auto-injectors (such as EPIPEN®) now available in Walgreens
30/08/2019
WATERLOO, Ontario, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Aterica Digital Health today announces the Walgreens in-store availability of Veta™ Smart Case & App – the first-ever comprehensive anaphylaxis and food allergy [...]
C-RAD AB – Interim report January-June 2019
30/08/2019
C-RAD AB – Interim report January-June 2019 RECORD HIGH ORDER BACK LOG JANUARY - JUNE 2019 Order intake: 64.1 (56.4) MSEK Order backlog: 214,5 (156,5) MSEK Revenues: 51.5 (51.9) MSEK EBITDA: 1.9 (3.1) MSEK Operating [...]
BBS Interim Report H1/2019
30/08/2019
BBS-Bioactive Bone Substitutes Plc (BBS) Interim Report January 1th – June 30th 2019 (unaudited) January-June shortly (comparison season 1-6/2018) Updates as required by the new Medical Device Regulation (MDR 2017/745) [...]
Tania Micki to succeed long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 annual financial statements
30/08/2019
Männedorf, Switzerland, August 30, 2019 – Tecan Group Ltd. (SIX Swiss Exchange: TECN) announced today that the Board of Directors has appointed Tania Micki to succeed Dr. Rudolf Eugster as Chief Financial Officer (CFO) [...]
Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Sclerosis Studies
30/08/2019
Company Announcement In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate (ARR) over teriflunomide in patients with relapsing forms of multiple sclerosis (RMS) Key [...]
Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies
30/08/2019
In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over Aubagio ®* (teriflunomide) in patients with relapsing forms of MS (RMS)[1] Key secondary endpoints of delaying [...]
Media Advisory - Save Your Skin Launches Inaugural “Move For Melanoma” Challenge Benefiting Skin Cancer Patients Across Canada
30/08/2019
The unique physical activity challenge takes place across Canada from September 13-16 VANCOUVER, British Columbia, Aug. 30, 2019 (GLOBE NEWSWIRE) -- On Friday, September 13 th Save Your Skin Foundation will officially [...]
ObsEva SA to Participate in Upcoming Investor Conferences
30/08/2019
Geneva, Switzerland and Boston, MA – August 30, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Bone Therapeutics reports half year 2019 results
30/08/2019
Regulated information The interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can [...]
Bone Therapeutics publie ses résultats du premier semestre 2019
30/08/2019
Information réglementée Le rapport semestriel est préparé conformément à l’article 13 de l’Arrêté Royal relatif aux obligations des émetteurs d’instruments financiers admis à la négociation sur un marché réglementé et [...]
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
30/08/2019
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]

Pages